About 20 Mg Octreotide For Injection
Octreotide 20, a best-seller among parenteral therapies, is a first-class solution procured to manage acromegaly, neuroendocrine tumors, carcinoid syndrome, and vasoactive intestinal peptide tumors. This single-use vial features a sterile, white to off-white lyophilized powder composed of Octreotide Acetate 20 mg, USP compliant, and manufactured to remarkable United States Pharmacopeia standards. Strictly prescription-only, its high purity ensures sterling results for clinical applications, with maximum dosing guided by physician direction. Scarce in lesser markets, Octreotide 20 promises reliability, latex-free packaging, and is transported under refrigerated conditions for optimum integrity.
Outstanding Features and Specific Applications
Octreotide 20 stands out due to its high purity, reliable sterility, and the convenience of single-use vial packaging. Specially formulated for treating acromegaly and neuroendocrine disorders, it must be reconstituted with 5 mL sterile water and can be administered subcutaneously or intravenously. The ready-to-use lyophilized powder delivers remarkable efficacy in controlling hormone-related symptoms. Its premium composition aligns with strict USP standards, making it a trusted choice for healthcare professionals seeking unwavering quality.
Logistics, Export Market & Packaging Details
Delivered in a sterile glass vial, Octreotide 20 exemplifies meticulous logistics suited for the global export market. Each shipment requires refrigerated transportation, safeguarding potency during transit. Payment terms are flexible and tailored to client requirements, while sample availability eases product evaluation for distributors and buyers alike. Packaging is robust, latex-free, and visually inspected for integrity, ensuring each unit reaches its destination in optimal condition-whether supplied across India or exported internationally.
FAQ's of 20 Mg Octreotide For Injection:
Q: How should Octreotide 20 Mg for Injection be reconstituted and administered?
A: Octreotide 20 should be reconstituted with 5 mL of sterile water for injection and administered either subcutaneously or intravenously, based on physician direction.
Q: What are the key benefits of using Octreotide 20 for acromegaly and neuroendocrine tumors?
A: The main benefits include targeted efficacy in controlling symptom progression, high purity and sterility, and compliance with USP standards, making it reliable for clinical use.
Q: Where is Octreotide 20 Mg for Injection manufactured and distributed?
A: It is manufactured according to United States Pharmacopeia standards and distributed across India and various international export markets.
Q: When should Octreotide 20 not be used?
A: Octreotide 20 is contraindicated in patients with hypersensitivity to octreotide or its excipients. It should only be used when prescribed by a qualified physician.
Q: What precautions need to be followed during Octreotide 20 therapy?
A: Blood glucose, thyroid function, and cardiac conditions should be monitored closely during therapy, as adverse effects may include gastrointestinal disorders and changes in glucose metabolism.
Q: How is the packaging of Octreotide 20 Mg for Injection ensured for safety during transportation?
A: It is packed in a sterile glass vial, latex-free, and requires refrigerated logistics to maintain its integrity until delivered. Visual inspection before reconstitution is mandatory for clinical safety.